| Primary information |
|---|
| sequence ID | Seq_7105 |
| Peptide sequence | SGGGGGGGLGSGGSIR |
| CancerPDF_ID | CancerPDF_ID9230, CancerPDF_ID12184, |
| PMID | 24694173,26992070 |
| Protein Name | "Keratin, type I cytoskeletal 9","Keratin, type I cytoskeletal 9" |
| UniprotKB Entry Name | K1C9_HUMAN,K1C9_HUMAN |
| Fluid | Ascites fluid,Serum |
| M/Z | NA,1231.5905 |
| Charge | 1,NA |
| Mass (in Da) | NA,1232.598436 |
| fdr | NA,NA |
| Profiling Technique | LTQ-Orbitrap XL,LC-MS |
| Peptide Identification technique | X tandem for peptide identification,LC-MS/MS |
| Quantification Technique | NA,NA |
| Labelled/Label Free | Label Free,Label Free |
| FDR | NA,FDR 1 % |
| CancerPDF_ID | CancerPDF_ID9230, CancerPDF_ID12184, |
| p-Value | NA,NA |
| Software | "X tandem for peptide identification,Scaffold 2 software for any modification analysis",SEQUEST and Maxquant |
| Length | 16,16 |
| Cancer Type | Ovarian cancer,Melanoma |
| Database | IPI00019359,SwissProt Database |
| Modification | NA,NA |
| Number of Patients | 3 ovarian cancer patient and 3 non cancerous control,8 cancer samples and 4 healthy samples |
| Regulation | Uniquely expressed in ovarian cancer patient,"Present in 8 cancer samples out of 8 cancer samples. ,Present in 4 healthy samples out of 4 healthy samples." |
| Validation | NA,na |
| Sensitivity | NA,NA |
| Specificity | NA,NA |
| Accuracy | NA,NA |
| Peptide Atlas | PeptideAtlas |
| IEDB | 240331
240393
240394
240524
240525
240526
|